| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.004 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.091 | 0.004 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.005 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.007 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.007 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.008 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.008 |